ARCHIVES

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

This article is from The Cancer Letter archive.

Vol. 21 No. 46 | December 1, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Meeting Moved To October

July 20, 1979

Senate Passes Non-Binding Resolution To Double NIH Budget Over Five Years

May 23, 1997

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Cancer Act Renewals Marked By Disputes Over NCI Authorities

October 5, 1990

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

FDA Approves Medication For Smoking Cessation

May 26, 2006